APT Insulin Selection in Type 2 Diabetes Mellitus with Different Comorbid Conditions

Authors

  • Arundhati Dasgupta Director and Senior Consultant Endocrinologist Rudraksh Superspeciality Care, Siliguri, India Author

DOI:

https://doi.org/10.47363/JONE/2021(1)103

Keywords:

Diabetes Mellitus

Abstract

In the current scenario, treatment of diabetes has become individualized and patient centric with customization of therapy being the key. Selection and adoption of insulin therapy now is driven by many factors like patient preference, co-morbid conditions, patient education and availability of insulin and cost of therapy [1]. This review attempts to discuss the rational use of different types of insulins in different situations.

Author Biography

  • Arundhati Dasgupta, Director and Senior Consultant Endocrinologist Rudraksh Superspeciality Care, Siliguri, India

    Arundhati Dasgupta, Director and Senior Consultant Endocrinologist Rudraksh Superspeciality Care, Siliguri, India.

Downloads

Published

2025-12-02